Latest clinical trials News | Page 43

Certainty offered for RDTI clinical trial activities
Lipids unlock opportunity for dietary supplement to reduce risk of Alzheimers disease
Trial of wearable health technology for cancer patients opens
High-tech eye drop research targets corneal damage
Proteins could be key to long and healthy life
ATAGI statement on use of Novavax Covid vaccine
Potent food supplement may help halt immune attack in people with diabetes
Antidepressant use and youth suicide
TGA provisionally approves Novavax Covid vaccine NUVAXOVID
R&D Tax Incentive draft determination for clinical trials: have your say
New assurance to support investment in clinical trials
PFIZER: TGA Approves Pfizer’s Novel Covid Oral Treatment in Australia
TGA provisionally approves two oral Covid treatments, molnupiravir and nirmatrelvir + ritonavir
Pharmaxis welcomes government research grants for new study collaborations
Recharged with resolutions for 2022
Australian study set to guide treatment of critically ill patients worldwide
First patient dosed in phase I/IIa trial of lung cancer immunotherapy vaccine
Enhertu granted Priority Review in US for patients with HER2-positive metastatic breast cancer treated with prior anti-HER2-based
Huge funding boost to launch Australia’s first collaborative cardiovascular research accelerator
Protective gene variant against Covid identified
Promising novel treatment for Dry Eye Disease revealed by new research
Pinpointing disease progression in ALS
Cutting through hype on platelet-rich plasma
Federal grants to fund liver cancer, tissue repair and skin disease projects
Moderna to build mRNA vaccine manufacturing facility in Australia
Researchers Reduce Breast Cancer Metastasis in Animal Models by Modifying Tumor Electrical Properties
$14.8 million for innovative mental health clinical trials 10 January
$14.8 million for innovative mental health clinical trials
Common osteoporosis medication boosts immune response in lun
$5.5 million for clinical trials to treat low-survival breast cancers
New study could inform treatment and prevent heart attack in diabetic patients
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Nasal spray to fight Covid heads to clinical trial
Covid – Omicron update from CMO Professor Paul Kelly 23 December
Interim statement on booster doses for Covid vaccination 23 December
Medical Research Future Fund support for clincial trials of mRNA-based vaccines and therapeutics
Top 3 Covid vaccine questions – children and vaccine, 11 year olds and vaccine, and boosters for ages 12-17
Government confirms Covid vaccinations to protect tamariki
Alternative statistical method could improve clinical trials
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Tezspire approved in US for severe asthma
Reducing copper alters breast cancer metabolism
Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer
Treating long-term brain damage after exposure to nerve agents
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
QIMR Berghofer attracts support for potential multiple sclerosis treatment
Naturopathic Centre makes significant progress despite 2021 headwinds
Clinical trial of potential treatments for abnormal blood lipid levels